Cepheid

E261817

Cepheid is a molecular diagnostics company known for its rapid, automated PCR-based testing systems used in clinical and research settings.

All labels observed (1)

Label Occurrences
Cepheid canonical 1

How this entity was disambiguated

Statements (51)

Predicate Object
instanceOf biotechnology company
medical device manufacturer
molecular diagnostics company
acquiredBy Danaher Corporation
acquisitionDate 2016
applicationArea clinical diagnostics
hospital laboratories
infectious disease testing
point-of-care testing
public health laboratories
research laboratories
coreTechnology automated sample preparation
polymerase chain reaction
real-time PCR
country United States of America
surface form: United States
developsTestFor Clostridioides difficile
Group B Streptococcus
HIV
SARS-CoV-2
hepatitis C virus
influenza
methicillin-resistant Staphylococcus aureus
rifampin-resistant tuberculosis
sexually transmitted infections
tuberculosis
feature integrated sample-to-answer workflow
random-access testing
rapid turnaround time
foundedBy H. Ward Wolff
Thomas Gutshall
headquartersLocation Sunnyvale, California, United States
inception 1996
industry in vitro diagnostics
medical devices
molecular diagnostics
knownFor GeneXpert system
automated molecular testing systems
rapid PCR-based diagnostic tests
market global
parentOrganization Danaher Corporation
product GeneXpert system
surface form: GeneXpert

GeneXpert system
surface form: GeneXpert Infinity

Xpert test cartridges
serves hospitals
public health agencies
reference laboratories
research institutions
status formerly publicly traded
stockExchange NASDAQ
surface form: Nasdaq
subsidiaryOf Danaher Corporation
tickerSymbol CPHD

How these facts were elicited

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.

Danaher Corporation owns Cepheid